⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRNX News
Crinetics Pharmaceuticals, Inc.
Form 8-K
sec.gov
CRNX
VRTX
Vertex to Acquire Crinetics Pharmaceuticals
businesswire.com
VRTX
CRNX
Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026
globenewswire.com
CRNX
Form 8-K
sec.gov
CRNX
Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
globenewswire.com
CRNX
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
globenewswire.com
CRNX
Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities
globenewswire.com
CRNX
Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations
globenewswire.com
CRNX
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026
globenewswire.com
CRNX
Form 8-K
sec.gov
CRNX